Equities
North America
Europe
Asia
Oceania
Middle East
South America
Africa
»
More Equities
Indexes
America
DOW JONES
NASDAQ COMP
S&P 500
NASDAQ 100
TSX COMP
MEXICO IPC
BOVESPA
Index and indicators
VOLATILITY
DOLLAR INDEX
»
More Indexes
Europe
FTSE 100
DAX
CAC 40
BEL 20
ATHEX COMP
RUSLAND RTS
SMI
IBEX 35
MILANO MIB
AEX
PSI 20
POLAND WIG
Asia, Pacific
NIKKEI 225
SHANGHAI COMP
HANG SENG
KOSPI COMP
SENSEX
TAIWAN TWSE
THAILAND 50
SYDNEY ASX
Middle East
EGX 30
TELAVIV 25
Commodities
Energy
Crude Oil (WTI)
Crude Oil (BRENT)
URANIUM
Index and indicators
CRB COMMODITY
BALTIC DRY
»
More Commodities
Metals
GOLD
SILVER
PLATINUM
PALLADIUM
ALUMINIUM
COPPER
LEAD
TIN
ZINC
Agriculture
COFFEE
SUGAR
CORN
COCOA
COTTOM
WHEAT
PALM IOL
SOYBEANS
Currencies
EUR / USD
USD / JPY
GBP / USD
AUD / USD
USD / CHF
USD / CAD
»
More Currencies
News
Latest News
Markets
Commodities
Business Leaders
Most Popular News
Hot News
Finance Calendar
Economic Calendar
Companies
All News
Press Releases
Events
Corporate actions
Economy & Forex
All News
Currencies / Forex
Economic Events
Press releases
Analysis
All Analysis
Commentaries
Stock Trading Strategies
Index Analysis
Forex Analysis
Commodity Analysis
Top & Flop
Gainers & Losers
Unusual Volumes
STIM
Top / Flop RSI
Top / Flop Gaps
Top / Flop Capitalizations
Market Screener
Technical Analysis
Oversold stocks
Overbought stocks
Close to resistances
Close to supports
Accumulation phase
Most volatile stocks
Fundamentals
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Market Screener
Sectors
Finance Calendar
Calendar
Finance Calendar
Economic Calendar
4-Traders Homepage
>
Shares
>
Euronext Alternext
>
HYBRIGENICS
ALHYG
FR0004153930
HYBRIGENICS
(ALHYG)
172
Delayed Euronext Alternext -
05/21 11:35:00 am
0.8
EUR
--.--%
04/08
HYBRIGENICS
: Update on the clinical study of inecalcitol in chronic lympho..
03/19
HYBRIGENICS
: Hybrigenics' technology platform applied to the study of the ..
03/14
HYBRIGENICS
: Hybrigenics' Technology Platform Successfully Applied to the ..
Summary
Quotes
Chart Analysis
News
Calendar
Company
Financials
Consensus
Revisions
Forum
Latest news on HYBRIGENICS
04/08
HYBRIGENICS
: Update on the clinical study of inecalcitol in chronic lymphocytic..
03/19
HYBRIGENICS
: Hybrigenics' technology platform applied to the study of the aging..
03/14
HYBRIGENICS
: Hybrigenics' Technology Platform Successfully Applied to the Study..
01/31
HYBRIGENICS
: 2012 revenues and update on the clinical study of inecalcitol in c..
01/29
HYBRIGENICS
: launches a new service to screen interactions between small molecu..
2012
HYBRIGENICS
: green ligt for two European patents protecting new oral formulatio..
2012
HYBRIGENICS
: launches a new website
2012
HYBRIGENICS
: Hybrigenics' first half 2012 revenues of EUR 2 million at the same..
2012
HYBRIGENICS
: Hybrigenics' General Meeting Highlights
2012
HYBRIGENICS
: Bryan, Garnier & Co initiates coverage of Hybrigenics with a targe..
2012
HYBRIGENICS
: Bryan Garnier initiates coverage of Hybrigenics with a target pric..
2012
HYBRIGENICS
: completed its private placement to institutional investors up to E..
2012
HYBRIGENICS
: gets approval and financing for a phase II clinical trial of oral ..
Advertisement
Chart
Duration :
Auto.
2 month
3 month
6 month
9 month
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Income Statement Evolution
More Financials
Loading...
Dynamic quotes
ON
|
OFF
My Watchlist
|
My Portfolio
Copyright © 2013 Surperformance. All rights reserved.